Regions of interest in the venous sinuses as input functions for quantitative PET.

UNLABELLED As clinical PET becomes increasingly available, quantitative methods that are feasible in busy clinical settings are becoming necessary. We investigated the use of intracranial blood pools as sources of an input function for quantitative PET. METHODS We studied 25 patients after the intravenous injection of [18F]6-fluoro-L-m-tyrosine and compared sampled blood time-activity curves with those obtained in small regions of interest (ROIs) defined in the blood pools visible in the PET images. Because of the comparatively large dimensions of the blood pool at the confluence of the superior sagittal, straight and transverse sinuses, a venous ROI input function was chosen for further analysis. We applied simple corrections to the ROI-derived time-activity curves, deriving expressions for partial volume, spillover and partition of tracer between plasma and red blood cells. The results of graphic and compartmental analysis using both sampled [Cs(t)] and ROI [Cr(t)] venous input functions for each patient were compared. We also used an analytic approach to examine possible differences between venous and arterial input functions in the cerebral circulation. RESULTS Cr(t) peaked significantly earlier and higher than Cs(t) in this patient population, although the total integral under the curves did not differ significantly. We report some apparent differences in the results of modeling using the two input functions; however, neither the graphically determined influx constant, Ki, nor the model parameter that reflects presynaptic dopaminergic metabolism, k3, differed significantly between the two methods. The analytic results suggest that the venous ROI input function may be closer to the arterial supply of radiotracer to the brain than arterialized venous blood, at least in some patient populations. CONCLUSION We present a simple method of obtaining an input function for PET that is applicable to a wide range of tracers and quantitative methods and is feasible for diagnostic PET imaging.

[1]  D. Feng,et al.  Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. , 1993, International journal of bio-medical computing.

[2]  O B Paulson,et al.  Asymmetrical Transport of Amino Acids across the Blood—Brain Barrier in Humans , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[4]  A. Gjedde,et al.  Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms , 1998, Synapse.

[5]  J. Mukherjee,et al.  Radiobrominated m-tyrosine analog as potential CNS L-dopa pet tracer. , 1988, Biochemical and biophysical research communications.

[6]  C. Patlak,et al.  Kinetic analysis of blood-brain barrier transport of D-glucose in man: quantitative evaluation in the presence of tracer backflux and capillary heterogeneity. , 1990, Microvascular research.

[7]  Raymond F. Muzic,et al.  A nonlinear spatially variant object-dependent system model for prediction of partial volume effects and scatter in PET , 1998, IEEE Transactions on Medical Imaging.

[8]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  M Diksic,et al.  Influence of the Input Function on the Calculation of the Local Cerebral Metabolic Rate for Glucose in the Deoxyglucose Method , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  M. Phelps,et al.  Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  M. Phelps,et al.  Tracer Kinetic Modeling in Positron Computed Tomography , 1983 .

[12]  A. Gjedde,et al.  6-[18F]fluoro-l-DOPA Metabolism in Living Human Brain: A Comparison of Six Analytical Methods , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  C. Nahmias,et al.  A probe for intracerebral aromatic amino‐acid decarboxylase activity: Distribution and kinetics of [18F]6‐fluoro‐L‐m‐tyrosine in the human brain , 1995, Movement disorders : official journal of the Movement Disorder Society.

[14]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  D. Norman,et al.  Reduced caliber of the internal carotid artery: a normal finding with ipsilateral absence or hypoplasia of the A1 segment. , 1996, AJNR. American journal of neuroradiology.

[16]  D. Feng,et al.  Noninvasive Quantification of the Cerebral Metabolic Rate for Glucose Using Positron Emission Tomography, 18F-Fluoro-2-Deoxyglucose, the Patlak Method, and an Image-Derived Input Function , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  A. Gjedde,et al.  Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  L Axel,et al.  Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. , 1983, Investigative radiology.

[19]  M. Mintun,et al.  Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  C. Nahmias,et al.  The Distribution and Kinetics of [18F]6-Fluoro-3-O-Methyl-l-Dopa in the Human Brain , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  J. Holden,et al.  Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  R. Chirakal,et al.  Synthesis of 18F labelled fluoro-m-tyrosine, fluoro-m-tyramine and fluoro-3-hydroxyphenylacetic acid , 1991 .

[23]  W H Wong,et al.  A clinically practical method to acquire parametric images of unidirectional metabolic rates and blood spaces. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  E. Hoffman,et al.  Noninvasive determination of local cerebral metabolic rate of glucose in man. , 1980, The American journal of physiology.

[25]  D. Feng,et al.  Simultaneous Extraction of Physiological and Input Function Parameters from PET Measurements 1 1Transcripts of the BRAINPET97 discussion of this chapter can be found in Section VIII. , 1998 .

[26]  K. Norwich Molecular Dynamics in Biosystems: The Kinetics of Tracers in Intact Organisms , 1977 .

[27]  K. B. Larson,et al.  Simultaneous MR Acquisition of Arterial and Brain Signal‐Time Curves , 1992, Magnetic resonance in medicine.

[28]  T. Ishikawa,et al.  Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  A. Lockwood Invasiveness in Studies of Brain Function by Positron Emission Tomography (PET) , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  J. Votaw,et al.  Performance evaluation of the Pico-Count flow-through detector for use in cerebral blood flow PET studies. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  W H Oldendorf,et al.  Measurement of the mean transit time of cerebral circulation by external detection of an intravenously injected radioisotope. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  V. Dhawan,et al.  Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. , 1993, Radiology.